Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

N-myc regulates parkin expression.

Andrew B West1, Gregory Kapatos, Casey O'Farrell

  • 1Morris K Udall Center for Parkinson's Disease Research, UCLA Neuropsychiatric Institute, Los Angeles, California 90024, USA. abwest7@yahoo.com

The Journal of Biological Chemistry
|April 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subjective and Objective Stress Responses of Third-Year Veterinary Students During Deliberate Practice on an Ovariohysterectomy Surgical Simulation Trainer.

Journal of veterinary medical education·2026
Same author

Rab12 is a regulator of mitophagy and mitochondrial homeostasis.

bioRxiv : the preprint server for biology·2026
Same author

Peripheral inflammation mediates midbrain Lrrk2 kinase activity via Rab32 expression.

bioRxiv : the preprint server for biology·2026
Same author

Vps35 p. D620N causes Lrrk2 kinase hyperactivity, chronic microglial activation and inflammation.

bioRxiv : the preprint server for biology·2026
Same author

How to discover novel genes that cause Parkinson's disease.

Current opinion in neurobiology·2026
Same author

The hidden world of nanoplastics colliding with neurodegenerative diseases.

The Journal of clinical investigation·2026
Same journal

Isotope-Edited ESEEM: A New Method for Probing Copper Binding Sites in Neurodegenerative Proteins.

The Journal of biological chemistry·2026
Same journal

Introduction to the Thematic Review Series on Intracellular Protein Degradation. The ubiquitous biology of intracellular protein degradation: a tribute to Alfred L. ("Fred") Goldberg.

The Journal of biological chemistry·2026
Same journal

Correction: Aromatic residue-rich amino-terminal segments of temporin L self-assemble into collagen-mimetic peptides with cell-adhesion properties.

The Journal of biological chemistry·2026
Same journal

YhbO is a DJ-1 family glyoxalase and α-oxoaldehyde hydratase that confers resistance to reactive carbonyl stress (112).

The Journal of biological chemistry·2026
Same journal

ARMH3 acts as a central scaffold at the Golgi/TGN through interactions with Arl5, GBF1, and PI4KB.

The Journal of biological chemistry·2026
Same journal

PAX8 controls proximal tubule epithelial identity and stress response through epigenetic modification of distal regulatory elements.

The Journal of biological chemistry·2026
See all related articles

Parkinson's disease (PD) gene parkin expression is repressed by N-myc. This study reveals a link between N-myc, cell cycle control, and Parkinson's disease pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Mutations in the parkin gene are linked to early-onset and familial Parkinson's disease (PD).
  • Parkin protein functions as an E3 ligase within the ubiquitin-proteasome system.
  • Regulatory pathways governing parkin gene expression remain largely unknown.

Purpose of the Study:

  • To investigate the regulatory mechanisms controlling parkin gene expression.
  • To identify transcription factors that interact with the parkin promoter.
  • To explore the relationship between N-myc, cell cycle control, and PD.

Main Methods:

  • Reporter assays to assess N-myc binding site function in the parkin promoter.
  • Chromatin immunoprecipitation (ChIP) assays to confirm N-myc binding to the parkin promoter.

Related Experiment Videos

  • Analysis of parkin and N-myc expression levels in various biological models, including developing brains and neuroblastoma cell lines.

    • Main Results:

    • A conserved N-myc binding site in the parkin promoter represses transcription.
    • N-myc directly binds to the parkin promoter, inhibiting its activity.
    • Parkin expression inversely correlates with N-myc levels in developing brains and neuroblastoma cells.
    • Retinoic acid-induced differentiation alters parkin and N-myc expression, but parkin modulation doesn't affect proliferation or cyclin E levels.
    • Genes associated with familial PD share N-myc and cell cycle-mediated transcriptional regulation.

    Conclusions:

    • N-myc acts as a transcriptional repressor of the parkin gene.
    • A common pathway involving N-myc, cell cycle control, and the ubiquitin-proteasome system may underlie Parkinson's disease.
    • These findings provide new insights into the molecular mechanisms of PD pathogenesis.